Literature DB >> 8054244

International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH).

N Baber1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8054244      PMCID： PMC1364893          DOI： 10.1111/j.1365-2125.1994.tb05705.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  33 in total

1.  Application of pharmacometric approaches to evaluate effect of weight and renal function on pharmacokinetics of alogliptin.

Authors:  Himanshu Naik; Richard Czerniak; Majid Vakilynejad
Journal:  Br J Clin Pharmacol       Date:  2016-02-22       Impact factor: 4.335

Review 2.  Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines.

Authors:  A Antal; I Alekseichuk; M Bikson; J Brockmöller; A R Brunoni; R Chen; L G Cohen; G Dowthwaite; J Ellrich; A Flöel; F Fregni; M S George; R Hamilton; J Haueisen; C S Herrmann; F C Hummel; J P Lefaucheur; D Liebetanz; C K Loo; C D McCaig; C Miniussi; P C Miranda; V Moliadze; M A Nitsche; R Nowak; F Padberg; A Pascual-Leone; W Poppendieck; A Priori; S Rossi; P M Rossini; J Rothwell; M A Rueger; G Ruffini; K Schellhorn; H R Siebner; Y Ugawa; A Wexler; U Ziemann; M Hallett; W Paulus
Journal:  Clin Neurophysiol       Date:  2017-06-19       Impact factor: 3.708

3.  Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis.

Authors:  Paul A MacMullan; Anne M Madigan; Nevin Paul; Aaron J Peace; Ahmed Alagha; Kevin B Nolan; Geraldine M McCarthy; Dermot Kenny
Journal:  Clin Rheumatol       Date:  2014-09-26       Impact factor: 2.980

4.  Development and validation of a rapid, aldehyde dehydrogenase bright-based cord blood potency assay.

Authors:  Kevin Shoulars; Pamela Noldner; Jesse D Troy; Lynn Cheatham; Amanda Parrish; Kristin Page; Tracy Gentry; Andrew E Balber; Joanne Kurtzberg
Journal:  Blood       Date:  2016-03-11       Impact factor: 22.113

5.  Step-wise loss of antidepressant effectiveness with repeated antidepressant trials in bipolar II depression.

Authors:  Jay D Amsterdam; Lorenzo Lorenzo-Luaces; Robert J DeRubeis
Journal:  Bipolar Disord       Date:  2016-11-02       Impact factor: 6.744

6.  The use of non-target high-resolution mass spectrometry screening to detect the presence of antibiotic residues in urban streams of Greensboro North Carolina.

Authors:  Austin Gray
Journal:  J Environ Health Sci Eng       Date:  2021-06-21

7.  Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis.

Authors:  Amit Gaggar; Junliang Chen; James F Chmiel; Henry L Dorkin; Patrick A Flume; Rhonda Griffin; David Nichols; Scott H Donaldson
Journal:  J Cyst Fibros       Date:  2015-08-28       Impact factor: 5.482

8.  Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.

Authors:  Ghassan K Abou-Alfa; Teresa Macarulla; Milind M Javle; Robin K Kelley; Sam J Lubner; Jorge Adeva; James M Cleary; Daniel V Catenacci; Mitesh J Borad; John Bridgewater; William P Harris; Adrian G Murphy; Do-Youn Oh; Jonathan Whisenant; Maeve A Lowery; Lipika Goyal; Rachna T Shroff; Anthony B El-Khoueiry; Bin Fan; Bin Wu; Christina X Chamberlain; Liewen Jiang; Camelia Gliser; Shuchi S Pandya; Juan W Valle; Andrew X Zhu
Journal:  Lancet Oncol       Date:  2020-05-13       Impact factor: 41.316

9.  Adverse drug reactions of Yunnan Baiyao capsule: a multi-center intensive monitoring study in China.

Authors:  Bo Li; Shuo Feng; Zhi-Hong Wu; Joey S W Kwong; Jing Hu; Nan Wu; Gui-Hua Tian; Hong-Cai Shang; Gui-Xing Qiu
Journal:  Ann Transl Med       Date:  2019-03

10.  Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies.

Authors:  Salwa Salah; Azza A Mahmoud; Amany O Kamel
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.